Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
DexCom IncDXCM50.998.7817.5435.2232.06%6.49%51.91$86.64$91.51135,069$88.07

Detail of DexCom Inc

 
CEO
Mr. Kevin Ronald Sayer
Employees
9500
Industry
Medical Devices
Sector
Healthcare
Market cap
$35B

Company details

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$3.95B
Cost of goods (CoG)
-$1.52B
Gross profit (GP)
$2.44B
Operating expense (OE)
-$1.82B
Research and development (R&D)
-$549.00M
General and administrative (G&A)
-$1.27B
Operating income (OI)
$628.00M
Other income expense (OIE)
-$3.40M
Pretax income (PI)
$743.90M
Tax (TAX)
-$63.10M
Net income (NI)
$680.80M
DexCom Inc
DXCM • XNGS • US
$88.07
-32.39 (-26.89%)
Stock vs Industry average
  • Industry average

Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
$1.73
Margin profit
17.22%
52 week low
$64.00
52 week high
$140.449997
50-day simple moving average
$87.53
200-day simple moving average
$86.64
Percent held by insiders
1.01%
Percent held by institutions
97.27%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
DXCM -25.62%
eps change
DXCM +9.68%